MLL advised KRÜGER GROUP, a German food and beverage manufacturer, producing and selling food products, specialising in beverages, chocolate and sugar confectionery, infant formula, health products, OTC and pharmaceutical products and semi-finished products for
Search Results for: MLL
Binder Legal strenghtens its Zurich office with the hire of three partners: Anna Neukom Chaney (pictured left), Dr Daniel Küpfer (pictured center) and Marco S. Meier (pictured right) who joined Binder as of 1 July 2024.
MLL advised Backed Finance on all Swiss legal and regulatory aspects in establishing and launching Backed Assets as the Swiss issuer of tokenized structured products, the tokenization service provider Backed Finance and the later move
MLL promoted Andrea Schäffler (pictured left) and Marc Baumberger (pictured right) to Senior Associates. Andrea Schäffler Andrea Schäffler is part of MLL’s IP team. She represents and advises clients in all
MLL Legal strengthens its Lausanne office with the arrival of a team of three partners and two associates. By strengthening its presence in Lausanne, MLL Legal also shows its commitment to further develop its skills
Baker McKenzie advised Investis on the sale of its entire real estate services business to PHM Group Oy (“PHM”), a pan-European real estate services provider advised by MLL. The enterprise value amounts to CHF 240 million,
MLL advised Vsquared Ventures as lead investor in the USD 11 million seed financing round of Synthara, advised by Kellerhals Carrard. The financing successfully closed on 5 June 2024 and included OTB Ventures, Onsight Ventures, Deep Tech Labs,
MLL in collaboration with Oberhammer Rechtsanwälte advised Mirus Software, a Swiss provider of software solutions in the hospitality industry, which is part of the Austrian group Alpha VCX active in IT and software businesses,
MLL advised Plasmalex on the acquisition of the swiss company Coat-X. The incorporation of implantable multilayer COAT-X thin films into Plasmalex’s product range represents a significant expansion of Plasmalex’s portfolio and will enable